News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
71,314 Results
Type
Article (11903)
Company Profile (30)
Press Release (59379)
Multimedia
Podcasts (52)
Webinars (7)
Section
Business (19166)
Career Advice (1668)
Deals (2918)
Drug Delivery (63)
Drug Development (8569)
Employer Resources (112)
FDA (1947)
Job Trends (2211)
News (32106)
Policy (4685)
Tag
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (686)
Accelerated approval (15)
ADA (14)
Adcomms (16)
Allergies (44)
Alliances (4319)
ALS (40)
Alzheimer's disease (290)
Antibody-drug conjugate (ADC) (87)
Approvals (1846)
Artificial intelligence (187)
ASCO (49)
Autoimmune disease (44)
Automation (11)
Bankruptcy (48)
Best Places to Work (1611)
BIO (13)
BIOSECURE Act (11)
Biosimilars (39)
BioSpace Insights (50)
Biotechnology (21)
Bladder cancer (25)
Brain cancer (15)
Breast cancer (88)
Cancer (824)
Cardiovascular disease (77)
Career advice (1397)
Career pathing (46)
CAR-T (60)
CDC (30)
Celiac Disease (1)
Cell therapy (206)
Cervical cancer (8)
Clinical research (6811)
Collaboration (308)
Commercialization (2)
Company closure (5)
Compensation (85)
Complete response letters (30)
COVID-19 (788)
CRISPR (29)
C-suite (183)
Cystic fibrosis (16)
Data (1014)
Decentralized trials (1)
Denatured (7)
Depression (54)
Dermatology (19)
Diabetes (129)
Diagnostics (731)
Digital health (11)
Diversity (6)
Diversity, equity & inclusion (29)
Drug discovery (92)
Drug pricing (99)
Drug shortages (13)
Duchenne muscular dystrophy (52)
Earnings (5201)
Editorial (70)
Employer branding (11)
Employer resources (104)
Events (8342)
Executive appointments (127)
FDA (2475)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (320)
Gene editing (60)
Generative AI (24)
Gene therapy (194)
GLP-1 (314)
Government (1113)
Grass and pollen (2)
Guidances (44)
Healthcare (2646)
Hematology (23)
HIV (29)
Huntington's disease (21)
IgA nephropathy (9)
Immunology and inflammation (81)
Immuno-oncology (25)
Indications (23)
Infectious disease (857)
Inflammatory bowel disease (30)
Inflation Reduction Act (5)
Influenza (23)
Intellectual property (28)
Interviews (330)
IPO (1105)
IRA (26)
Job creations (570)
Job search strategy (1116)
JPM (41)
Kidney cancer (3)
Labor market (73)
Layoffs (184)
Leadership (43)
Legal (1649)
Liver cancer (15)
Longevity (8)
Lung cancer (108)
Lymphoma (54)
Machine learning (21)
Management (42)
Manufacturing (216)
Marketing (4)
MASH (23)
Medical affairs (1)
Medical device (1318)
Medtech (1338)
Mergers & acquisitions (1961)
Metabolic disorders (423)
mRNA (84)
Multiple sclerosis (14)
NASH (4)
Neurodegenerative disease (94)
Neuropsychiatric disorders (29)
Neuroscience (569)
NextGen: Class of 2026 (1252)
Non-profit (952)
Now hiring (16)
Obesity (255)
Opinion (265)
Ovarian cancer (19)
Pain (48)
Pancreatic cancer (46)
Parkinson's disease (49)
Partnered (18)
Patents (70)
Patient recruitment (84)
Peanut (7)
People (5647)
Pharmaceutical (4)
Pharmacy benefit managers (10)
Phase 1 (2250)
Phase 2 (2946)
Phase 3 (2447)
Pipeline (1278)
Policy (195)
Postmarket research (252)
Preclinical (853)
Press Release (8)
Prostate cancer (37)
Psychedelics (32)
Radiopharmaceuticals (37)
Rare diseases (316)
Real estate (794)
Recruiting (50)
Regulatory (3024)
Reports (11)
Research institute (542)
Resumes & cover letters (291)
Rett syndrome (12)
RNA editing (6)
RSV (14)
Schizophrenia (27)
Series A (57)
Series B (37)
Service/supplier (1)
Sickle cell disease (29)
Special edition (13)
Spinal muscular atrophy (21)
Sponsored (19)
Startups (562)
Stomach cancer (5)
Supply chain (30)
Tariffs (49)
The Weekly (44)
Vaccines (333)
Venture capital (64)
Weight loss (210)
Women's health (33)
Worklife (20)
Date
Today (14)
Last 7 days (51)
Last 30 days (271)
Last 365 days (3556)
2026 (2307)
2025 (3686)
2024 (3696)
2023 (3852)
2022 (4838)
2021 (5670)
2020 (5651)
2019 (6116)
2018 (4806)
2017 (3559)
2016 (3767)
2015 (4141)
2014 (2762)
2013 (2113)
2012 (2365)
2011 (2439)
2010 (1660)
Location
Africa (325)
Alabama (8)
Alaska (1)
Arizona (18)
Arkansas (3)
Asia (3758)
Australia (831)
California (1646)
Canada (382)
China (151)
Colorado (60)
Connecticut (70)
Delaware (51)
Europe (9198)
Florida (189)
Georgia (33)
Idaho (5)
Illinois (115)
India (11)
Indiana (59)
Japan (69)
Kansas (30)
Kentucky (11)
Louisiana (11)
Maine (7)
Maryland (222)
Massachusetts (985)
Michigan (40)
Minnesota (52)
Mississippi (2)
Missouri (14)
Montana (5)
Nebraska (1)
Nevada (18)
New Hampshire (11)
New Jersey (336)
New Mexico (4)
New York (530)
North Carolina (121)
Northern California (727)
Ohio (43)
Oklahoma (5)
Oregon (5)
Pennsylvania (229)
Puerto Rico (1)
Rhode Island (8)
South America (346)
South Carolina (13)
Southern California (686)
Tennessee (22)
Texas (219)
United States (5172)
Utah (45)
Virginia (45)
Washington D.C. (20)
Washington State (81)
West Virginia (2)
Wisconsin (20)
71,314 Results for "just biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Atara Biotherapeutics Announces Second Quarter 2026 Financial Results and Operational Progress
August 13, 2026
·
9 min read
Press Releases
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 14, 2026
·
9 min read
Press Releases
Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 11, 2026
·
10 min read
Press Releases
Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering
August 7, 2026
·
4 min read
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - August 21, 2026
August 23, 2026
·
3 min read
Press Releases
Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 7, 2026
·
11 min read
Press Releases
First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026
·
8 min read
Press Releases
Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update
August 10, 2026
·
18 min read
Press Releases
Latigo Biotherapeutics Appoints Todd Smith to its Board of Directors
July 8, 2026
·
2 min read
Press Releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 7, 2026
August 9, 2026
·
3 min read
1 of 7,132
Next
